drugset / Trial / NCT00792714
Pharmacokinetics of Inhaled Mannitol in Cystic Fibrosis Patients
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The general objective of the study is to estimate the systemic pharmacokinetics of mannitol after single and multiple dosing of IDPM 400 mg to adult and paediatric cystic fibrosis patients.
Timeline
- Start
- 2008-12
- Primary completion
- 2009-09
- Completion
- 2009-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mannitol | Diagnostic / imaging agent | 400 mg | Inhaled |